2seventy bio, Inc.
TSVT
$3.10
$0.4516.98%
| 09/30/2023 | 06/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -66.62% | -13.39% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -66.62% | -13.39% | |||
| Cost of Revenue | -12.75% | -11.09% | |||
| Gross Profit | -55.51% | 7.99% | |||
| SG&A Expenses | -33.28% | -5.94% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -17.51% | -9.95% | |||
| Operating Income | -19.41% | 7.17% | |||
| Income Before Tax | -70.21% | 10.49% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -70.21% | 10.49% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -70.21% | 10.49% | |||
| EBIT | -19.41% | 7.17% | |||
| EBITDA | -19.22% | 7.46% | |||
| EPS Basic | -69.51% | 23.66% | |||
| Normalized Basic EPS | -20.62% | 23.63% | |||
| EPS Diluted | -69.51% | 23.66% | |||
| Normalized Diluted EPS | -20.62% | 23.63% | |||
| Average Basic Shares Outstanding | 0.42% | 17.25% | |||
| Average Diluted Shares Outstanding | 0.42% | 17.25% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
